Exome sequencing reveals riboflavin transporter mutations as a cause of motor neuron disease
Open Access
- 26 June 2012
- journal article
- research article
- Published by Oxford University Press (OUP) in Brain
- Vol. 135 (9), 2875-2882
- https://doi.org/10.1093/brain/aws161
Abstract
Brown–Vialetto–Van Laere syndrome was first described in 1894 as a rare neurodegenerative disorder characterized by progressive sensorineural deafness in combination with childhood amyotrophic lateral sclerosis. Mutations in the gene, SLC52A3 (formerly C20orf54), one of three known riboflavin transporter genes, have recently been shown to underlie a number of severe cases of Brown–Vialetto–Van Laere syndrome; however, cases and families with this disease exist that do not appear to be caused by SLC52A3 mutations. We used a combination of linkage and exome sequencing to identify the disease causing mutation in an extended Lebanese Brown–Vialetto–Van Laere kindred, whose affected members were negative for SLC52A3 mutations. We identified a novel mutation in a second member of the riboflavin transporter gene family (gene symbol: SLC52A2) as the cause of disease in this family. The same mutation was identified in one additional subject, from 44 screened. Within this group of 44 patients, we also identified two additional cases with SLC52A3 mutations, but none with mutations in the remaining member of this gene family, SLC52A1. We believe this strongly supports the notion that defective riboflavin transport plays an important role in Brown–Vialetto–Van Laere syndrome. Initial work has indicated that patients with SLC52A3 defects respond to riboflavin treatment clinically and biochemically. Clearly, this makes an excellent candidate therapy for the SLC52A2 mutation-positive patients identified here. Initial riboflavin treatment of one of these patients shows promising results.Keywords
This publication has 13 references indexed in Scilit:
- Novel genomic techniques open new avenues in the analysis of monogenic disordersHuman Mutation, 2011
- Brown‐Vialetto‐Van Laere and Fazio Londe syndrome is associated with a riboflavin transporter defect mimicking mild MADD: a new inborn error of metabolism with potential treatmentJournal of Inherited Metabolic Disease, 2010
- Maternal riboflavin deficiency, resulting in transient neonatal-onset glutaric aciduria Type 2, is caused by a microdeletion in the riboflavin transporter gene GPR172BHuman Mutation, 2010
- Exome Sequencing in Brown-Vialetto-Van Laere SyndromeAmerican Journal of Human Genetics, 2010
- Identification and Comparative Functional Characterization of a New Human Riboflavin Transporter hRFT3 Expressed in the BrainJournal of Nutrition, 2010
- Brown-Vialetto-Van Laere Syndrome, a Ponto-Bulbar Palsy with Deafness, Is Caused by Mutations in C20orf54American Journal of Human Genetics, 2010
- Brown-Vialetto-Van Laere syndromeOrphanet Journal of Rare Diseases, 2008
- Genomewide SNP assay reveals mutations underlying Parkinson diseaseHuman Mutation, 2007
- Application of Genome-Wide Single Nucleotide Polymorphism Typing: Simple Association and BeyondPLoS Genetics, 2006
- Ponto-bulbar palsy with deafness (Brown-Vialetto-Van Laere syndrome)Journal of the Neurological Sciences, 1981